Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization. - Wikidata - wikimedia - TriplyDB

Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.

Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.

http://www.wikidata.org/entity/Q37495266

about

Lowering Heart Rate Post Revascularization: Angina and Quality of Life Improvement.Role of ivabradine in management of stable angina in patients with different clinical profiles.

P2860

Q51518901-03EE72CB-3553-45B0-8995-A32F42A1229F Q54961020-D0777832-F423-4C89-8925-893FD1A18E46

P2860

Antianginal Efficacy of Ivabradine in Patients With History of Coronary Revascularization.

http://www.wikidata.org/entity/Q37495266

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@en

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@nl

type

label

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@en

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@nl

prefLabel

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@en

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@nl

P1433

Q37495266-76E2EB6F-D0F1-4655-B1C0-47D893FCE3D5

P1476

Q37495266-4291BE10-7071-49D3-BF79-695DD4ED06F5

P2093

Q37495266-16E43FB0-8945-4A23-8DCE-7E9D2EA9D12B

Q37495266-3F0C15F0-0F2E-42DA-BEF7-C5CA1E524C1A

Q37495266-5A17ACDE-AD8E-4DDB-B3FD-49F425804EEE

Q37495266-5B55D36A-EA12-4B0D-AB03-6DAD963E2B84

P2860

Q37495266-030C3DE3-3A39-40A8-A0A4-41461017CF33

Q37495266-13F5B451-F5B6-44A9-A01D-D1C3C4446FD0

Q37495266-188CF109-B05B-4F9E-AF79-AFB1E26A9C94

Q37495266-18D238D2-11D3-44F8-B93B-431EFA6891EC

Q37495266-21E51FB9-477B-4B5E-ACC3-BDD10F79B9B5

Q37495266-2212FDC5-79FB-43B1-9804-F2F90FDA374B

Q37495266-2F3E9C71-04CF-4431-8486-CA304E47CEC7

Q37495266-31AF6D85-F617-41D0-9473-97AC680BEED4

Q37495266-330EEA68-AFD6-4B70-8609-1D591ED3790A

Q37495266-3BDBE902-1D6C-49F6-AC5A-F960C15CC715

P304

Q37495266-F204130A-7950-469E-B21E-59C6BC896A32

P31

Q37495266-0DB3FC94-15A5-4F28-A210-D8B2338071E3

P356

Q37495266-FED47870-8CC1-4A2B-B8C2-6493CDE1B46B

P433

Q37495266-CF7F9391-99D6-49D7-BE06-A36821E7451B

P478

Q37495266-FCBD8CE8-2644-48F5-BE1F-AD8F7867849E

P577

Q37495266-D3A6F306-FADA-418A-8C49-DD27F375CD81

P5875

Q37495266-A41D52E2-20A1-440B-AADF-00A600916BA1

P698

Q37495266-DCB28A56-3AE4-466C-AC7F-7A3D1F7C7077

P921

Q37495266-9FEB2CC3-F64D-4D82-A915-03288E9C66D2

P932

Q37495266-40D8F1E4-6CAE-411F-BCAA-07AE53130A71

P356

0003319716630499

P1433

P1476

Antianginal Efficacy of Ivabra ...... of Coronary Revascularization.

@en

P2093

A Katsivas

http://www.w3.org/2001/XMLSchema#string

J Zarifis

http://www.w3.org/2001/XMLSchema#string

M Kallistratos

http://www.w3.org/2001/XMLSchema#string

V Grammatikou

http://www.w3.org/2001/XMLSchema#string

P2860

PCI for stable coronary disease

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, a

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.

Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.

Clinical practice. Chronic stable angina.

P304

10-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0003319716630499

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

297720932

http://www.w3.org/2001/XMLSchema#string

P698

26960667

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

P932

5152794

http://www.w3.org/2001/XMLSchema#string